Therapy of metastatic malignant melanoma using Xomazyme Mel, a murine monoclonal anti-melanoma ricin A chain immunotoxin.
Spitler
L E
LE
Biotherapeutics of San Francisco, Inc., Oakland, CA 94606.
Mischak
R
R
Scannon
P
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D000922:Immunotoxins / Q000009:adverse effects / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D012276:Ricin / Q000009:adverse effects / Q000627:therapeutic use*
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D000922:Immunotoxins; C059257:XomaZyme; D012276:Ricin